Alternative mRNA transcription, processing, and translation: Insights from RNA sequencing

Trends in Genetics

Volumn 31, Issue 3, 2015, Pages 128-139

  de Klerk, Eleonora ^a   't Hoen, Peter A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alternative polyadenylation; Alternative splicing; Gene expression; RNA sequencing; Transcriptome; Translation

Indexed keywords

MESSENGER RNA; POLYADENYLIC ACID; RNA BINDING PROTEIN; TRANSCRIPTOME;

5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; CELL DIFFERENTIATION; CPG ISLAND; ENHANCER REGION; EXON SKIPPING; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; HUMAN; INTRON; NONHUMAN; OPEN READING FRAME; POLYADENYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN RNA BINDING; REVIEW; RIBOSOME; RNA CAPPING; RNA PROCESSING; RNA SEQUENCE; RNA STRUCTURE; RNA TRANSCRIPTION; RNA TRANSLATION; STOP CODON; TATA BOX; TRANSCRIPTION INITIATION; TRANSCRIPTION INITIATION SITE; TRANSCRIPTION REGULATION; TRANSLATION INITIATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETICS; HIGH THROUGHPUT SEQUENCING; PROCEDURES; PROTEIN SYNTHESIS; SEQUENCE ANALYSIS;

ALTERNATIVE SPLICING; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; POLYADENYLATION; PROMOTER REGIONS, GENETIC; PROTEIN BIOSYNTHESIS; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; TRANSCRIPTION, GENETIC; TRANSCRIPTOME;

EID: 84923546513     PISSN: 01689525     EISSN: 13624555     Source Type: Journal    
DOI: 10.1016/j.tig.2015.01.001     Document Type: Review

References (147)

1. Djebali S., et al. Landscape of transcription in human cells. Nature 2012, 489:101-108.
2. Neph S., et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 2012, 489:83-90.
3. Sanyal A., et al. The long-range interaction landscape of gene promoters. Nature 2012, 489:109-113.
4. A promoter-level mammalian expression atlas. Nature 2014, 507:462-470. FANTOM Consortium and RIKEN PMI and CLST (DGT).
5. Goossens S., et al. Truncated isoform of mouse αT-catenin is testis-restricted in expression and function. FASEB J. 2007, 21:647-655.
6. Barbosa C., et al. Gene expression regulation by upstream open reading frames and human disease. PLoS Genet. 2013, 9:e1003529.
7. Calvo S.E., et al. Upstream open reading frames cause widespread reduction of protein expression and are polymorphic among humans. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7507-7512.
8. Fritsch C., et al. Genome-wide search for novel human uORFs and N-terminal protein extensions using ribosomal footprinting. Genome Res. 2012, 22:2208-2218.
9. Yamashita R., et al. Small open reading frames in 5' untranslated regions of mRNAs. C. R. Biol. 2003, 326:987-991.
10. Slavoff S.A., et al. Peptidomic discovery of short open reading frame-encoded peptides in human cells. Nat. Chem. Biol. 2013, 9:59-64.
11. Magny E.G., et al. Conserved regulation of cardiac calcium uptake by peptides encoded in small open reading frames. Science 2013, 341:1116-1120.
12. Jorgensen R.A., Dorantes-Acosta A.E. Conserved peptide upstream open reading frames are associated with regulatory genes in angiosperms. Front. Plant Sci. 2012, 3:191.
13. Shiraki T., et al. Cap analysis gene expression for high-throughput analysis of transcriptional starting point and identification of promoter usage. Proc. Natl. Acad. Sci. U.S.A. 2002, 100:15776-15781.
14. de Klerk E., et al. RNA sequencing: from tag-based profiling to resolving complete transcript structure. Cell. Mol. Life Sci. 2014, 71:3537-3551.
15. de Hoon M., Hayashizaki Y. Deep cap analysis gene expression (CAGE): genome-wide identification of promoters, quantification of their expression, and network inference. Biotechniques 2008, 44:627-628. 630, 632.
16. Hestand M.S., et al. Tissue-specific transcript annotation and expression profiling with complementary next-generation sequencing technologies. Nucleic Acids Res. 2010, 38:e165.
17. Suzuki H., et al. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line. Nat. Genet. 2009, 41:553-562.
18. Valen E., et al. Genome-wide detection and analysis of hippocampus core promoters using DeepCAGE. Genome Res. 2009, 19:255-265.
19. Gustincich S., et al. The complexity of the mammalian transcriptome. J. Physiol. 2006, 575:321-332.
20. Kapranov P., et al. RNA maps reveal new RNA classes and a possible function for pervasive transcription. Science 2007, 316:1484-1488.
21. Andersson R., et al. An atlas of active enhancers across human cell types and tissues. Nature 2014, 507:455-461.
22. Post-transcriptional processing generates a diversity of 5'-modified long and short RNAs. Nature 2009, 457:1028-1032. Affymetrix/Cold Spring Harbor Laboratory ENCODE Transcriptome Project.
23. Otsuka Y., et al. Identification of a cytoplasmic complex that adds a cap onto 5'-monophosphate RNA. Mol. Cell. Biol. 2009, 29:2155-2167.
24. Vitezic M., et al. Building promoter aware transcriptional regulatory networks using siRNA perturbation and DeepCAGE. Nucleic Acids Res. 2010, 38:8141-8148.
25. Levanon D., Groner Y. Structure and regulated expression of mammalian RUNX genes. Oncogene 2004, 23:4211-4219.
26. Steinthorsdottir V., et al. Multiple novel transcription initiation sites for NRG1. Gene 2004, 342:97-105.
27. Davis W., Schultz R.M. Developmental change in TATA-box utilization during preimplantation mouse development. Dev. Biol. 2000, 218:275-283.
28. Pozner A., et al. Developmentally regulated promoter-switch transcriptionally controls Runx1 function during embryonic hematopoiesis. BMC Dev. Biol. 2007, 7:84.
29. Pedersen I.S., et al. Promoter switch: a novel mechanism causing biallelic PEG1/MEST expression in invasive breast cancer. Hum. Mol. Genet. 2002, 11:1449-1453.
30. Agarwal V.R., et al. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J. Clin. Endocrinol. Metab. 1996, 81:3843-3849.
31. Tan W., et al. Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J. Biol. Chem. 2007, 282:24343-24351.
32. Hill R.E., Lettice L.A. Alterations to the remote control of Shh gene expression cause congenital abnormalities. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2013, 368:20120357.
33. Pan Q., et al. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet. 2008, 40:1413-1415.
34. Gonzalez-Porta M., et al. Transcriptome analysis of human tissues and cell lines reveals one dominant transcript per gene. Genome Biol. 2013, 14:R70.
35. Harrow J., et al. GENCODE: the reference human genome annotation for the ENCODE Project. Genome Res. 2012, 22:1760-1774.
36. Licatalosi D.D., et al. HITS-CLIP yields genome-wide insights into brain alternative RNA processing. Nature 2008, 456:464-469.
37. Ule J., et al. CLIP identifies Nova-regulated RNA networks in the brain. Science 2003, 302:1212-1215.
38. Wang E.T., et al. Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell 2012, 150:710-724.
39. Lebedeva S., et al. Transcriptome-wide analysis of regulatory interactions of the RNA-binding protein HuR. Mol. Cell 2011, 43:340-352.
40. Fu X.D., Ares M. Context-dependent control of alternative splicing by RNA-binding proteins. Nat. Rev. Genet. 2014, 15:689-701.
41. Zhang C., et al. Prediction of clustered RNA-binding protein motif sites in the mammalian genome. Nucleic Acids Res. 2013, 41:6793-6807.
42. Ameur A., et al. Total RNA sequencing reveals nascent transcription and widespread co-transcriptional splicing in the human brain. Nat. Struct. Mol. Biol. 2011, 18:1435-1440.
43. Hao S., Baltimore D. RNA splicing regulates the temporal order of TNF-induced gene expression. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:11934-11939.
44. Tilgner H., et al. Deep sequencing of subcellular RNA fractions shows splicing to be predominantly co-transcriptional in the human genome but inefficient for lncRNAs. Genome Res. 2012, 22:1616-1625.
45. Witten J.T., Ule J. Understanding splicing regulation through RNA splicing maps. Trends Genet. 2011, 27:89-97.
46. Yu Y., et al. Dynamic regulation of alternative splicing by silencers that modulate 5' splice site competition. Cell 2008, 135:1224-1236.
47. Wen J., et al. Computational identification of tissue-specific alternative splicing elements in mouse genes from RNA-seq. Nucleic Acids Res. 2010, 38:7895-7907.
48. Shepard P.J., Hertel K.J. Conserved RNA secondary structures promote alternative splicing. RNA 2008, 14:1463-1469.
49. Pervouchine D.D., et al. Evidence for widespread association of mammalian splicing and conserved long-range RNA structures. RNA 2012, 18:1-15.
50. Warf M.B., et al. The protein factors MBNL1 and U2AF65 bind alternative RNA structures to regulate splicing. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:9203-9208.
51. Yuan Y., et al. Muscleblind-like 1 interacts with RNA hairpins in splicing target and pathogenic RNAs. Nucleic Acids Res. 2007, 35:5474-5486.
52. Kertesz M., et al. Genome-wide measurement of RNA secondary structure in yeast. Nature 2010, 467:103-107.
53. Lucks J.B., et al. Multiplexed RNA structure characterization with selective 2'-hydroxyl acylation analyzed by primer extension sequencing (SHAPE-seq). Proc. Natl. Acad. Sci. U.S.A. 2011, 108:11063-11068.
54. Wan Y., et al. Landscape and variation of RNA secondary structure across the human transcriptome. Nature 2014, 505:706-709.
55. Ding Y., et al. In vivo genome-wide profiling of RNA secondary structure reveals novel regulatory features. Nature 2014, 505:696-700.
56. Giudice J., et al. Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development. Nat. Commun. 2014, 5:3603.
57. Kim K.K., et al. Rbfox3-regulated alternative splicing of Numb promotes neuronal differentiation during development. J. Cell Biol. 2013, 200:443-458.
58. Pimentel H., et al. A dynamic alternative splicing program regulates gene expression during terminal erythropoiesis. Nucleic Acids Res. 2014, 42:4031-4042.
59. Gracheva E.O., et al. Ganglion-specific splicing of TRPV1 underlies infrared sensation in vampire bats. Nature 2011, 476:88-91.
60. Buljan M., et al. Tissue-specific splicing of disordered segments that embed binding motifs rewires protein interaction networks. Mol. Cell 2012, 46:871-883.
61. Costa V., et al. RNA-seq and human complex diseases: recent accomplishments and future perspectives. Eur. J. Hum. Genet. 2013, 21:134-142.
62. Pistoni M., et al. Alternative splicing and muscular dystrophy. RNA Biol. 2010, 7:441-452.
63. Danckwardt S., et al. 3' End mRNA processing: molecular mechanisms and implications for health and disease. EMBO J. 2008, 27:482-498.
64. Andreassi C., Riccio A. To localize or not to localize: mRNA fate is in 3'UTR ends. Trends Cell Biol. 2009, 19:465-474.
65. Fabian M.R., et al. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 2010, 79:351-379.
66. Derti A., et al. A quantitative atlas of polyadenylation in five mammals. Genome Res. 2012, 22:1173-1183.
67. Ozsolak F., et al. Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation. Cell 2010, 143:1018-1029.
68. Shepard P.J., et al. Complex and dynamic landscape of RNA polyadenylation revealed by PAS-seq. RNA 2011, 17:761-772.
69. Yao C., et al. Transcriptome-wide analyses of CstF64-RNA interactions in global regulation of mRNA alternative polyadenylation. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:18773-18778.
70. de Klerk E., et al. Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation. Nucleic Acids Res. 2012, 40:9089-9101.
71. Ji Z., et al. Transcriptional activity regulates alternative cleavage and polyadenylation. Mol. Syst. Biol. 2011, 7:534.
72. Ni T., et al. Distinct polyadenylation landscapes of diverse human tissues revealed by a modified PA-seq strategy. BMC Genomics 2013, 14:615.
73. Hogg J.R., Goff S.P. Upf1 senses 3'UTR length to potentiate mRNA decay. Cell 2010, 143:379-389.
74. Ray D., et al. A compendium of RNA-binding motifs for decoding gene regulation. Nature 2013, 499:172-177.
75. Gupta I., et al. Alternative polyadenylation diversifies post-transcriptional regulation by selective RNA-protein interactions. Mol. Syst. Biol. 2014, 10:719.
76. Spies N., et al. 3' UTR-isoform choice has limited influence on the stability and translational efficiency of most mRNAs in mouse fibroblasts. Genome Res. 2013, 23:2078-2090.
77. Jenal M., et al. The poly(A)-binding protein nuclear 1 suppresses alternative cleavage and polyadenylation sites. Cell 2012, 149:538-553.
78. Martin G., et al. Genome-wide analysis of pre-mRNA 3' end processing reveals a decisive role of human cleavage factor I in the regulation of 3' UTR length. Cell Rep. 2012, 1:753-763.
79. Jan C.H., et al. Formation, regulation and evolution of Caenorhabditis elegans 3'UTRs. Nature 2011, 469:97-101.
80. Smibert P., et al. Global patterns of tissue-specific alternative polyadenylation in Drosophila. Cell Rep. 2012, 1:277-289.
81. Ulitsky I., et al. Extensive alternative polyadenylation during zebrafish development. Genome Res. 2012, 22:2054-2066.
82. Hafez D., et al. Genome-wide identification and predictive modeling of tissue-specific alternative polyadenylation. Bioinformatics 2013, 29:i108-i116.
83. Nunes N.M., et al. A functional human poly(A) site requires only a potent DSE and an A-rich upstream sequence. EMBO J. 2010, 29:1523-1536.
84. Tian B., et al. A large-scale analysis of mRNA polyadenylation of human and mouse genes. Nucleic Acids Res. 2005, 33:201-212.
85. Yan J., Marr T.G. Computational analysis of 3'-ends of ESTs shows four classes of alternative polyadenylation in human, mouse, and rat. Genome Res. 2005, 15:369-375.
86. Miura P., et al. Widespread and extensive lengthening of 3' UTRs in the mammalian brain. Genome Res. 2013, 23:812-825.
87. Hoque M., et al. Analysis of alternative cleavage and polyadenylation by 3' region extraction and deep sequencing. Nat. Methods 2013, 10:133-139.
88. Li Y., et al. Dynamic landscape of tandem 3' UTRs during zebrafish development. Genome Res. 2012, 22:1899-1906.
89. Mangone M., et al. The landscape of C. elegans 3'UTRs. Science 2010, 329:432-435.
90. Fu Y., et al. Differential genome-wide profiling of tandem 3' UTRs among human breast cancer and normal cells by high-throughput sequencing. Genome Res. 2011, 21:741-747.
91. Lin Y., et al. An in-depth map of polyadenylation sites in cancer. Nucleic Acids Res. 2012, 40:8460-8471.
92. Mayr C., Bartel D.P. Widespread shortening of 3'UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 2009, 138:673-684.
93. Lembo A., et al. Shortening of 3'UTRs correlates with poor prognosis in breast and lung cancer. PLoS ONE 2012, 7:e31129.
94. Morris A.R., et al. Alternative cleavage and polyadenylation during colorectal cancer development. Clin. Cancer Res. 2012, 18:5256-5266.
95. Batra R., et al. Loss of MBNL Leads to disruption of developmentally regulated alternative polyadenylation in RNA-mediated disease. Mol. Cell 2014, 56:311-322.
96. Kochetov A.V. Alternative translation start sites and hidden coding potential of eukaryotic mRNAs. Bioessays 2008, 30:683-691.
97. Ingolia N.T., et al. The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragments. Nat. Protoc. 2012, 7:1534-1550.
98. Ingolia N.T., et al. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 2011, 147:789-802.
99. Lee S., et al. Global mapping of translation initiation sites in mammalian cells at single-nucleotide resolution. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E2424-E2432.
100. Wasinger V.C., et al. Current status and advances in quantitative proteomic mass spectrometry. Int. J. Proteomics 2013, 2013:180605.
101. Menschaert G., et al. Deep proteome coverage based on ribosome profiling aids mass spectrometry-based protein and peptide discovery and provides evidence of alternative translation products and near-cognate translation initiation events. Mol. Cell. Proteomics 2013, 12:1780-1790.
102. Kozak M. Regulation of translation via mRNA structure in prokaryotes and eukaryotes. Gene 2005, 361:13-37.
103. Michel A.M., et al. Observation of dually decoded regions of the human genome using ribosome profiling data. Genome Res. 2012, 22:2219-2229.
104. Maier T., et al. Correlation of mRNA and protein in complex biological samples. FEBS Lett. 2009, 583:3966-3973.
105. Lundberg E., et al. Defining the transcriptome and proteome in three functionally different human cell lines. Mol. Syst. Biol. 2010, 6:450.
106. Schwanhausser B., et al. Global quantification of mammalian gene expression control. Nature 2011, 473:337-342.
107. Tian Q., et al. Integrated genomic and proteomic analyses of gene expression in mammalian cells. Mol. Cell. Proteomics 2004, 3:960-969.
108. Vogel C., et al. Sequence signatures and mRNA concentration can explain two-thirds of protein abundance variation in a human cell line. Mol. Syst. Biol. 2010, 6:400.
109. Ingolia N.T., et al. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 2009, 324:218-223.
110. Li J.J., et al. System wide analyses have underestimated protein abundances and the importance of transcription in mammals. PeerJ 2014, 2:e270.
111. Wang T., et al. Translating mRNAs strongly correlate to proteins in a multivariate manner and their translation ratios are phenotype specific. Nucleic Acids Res. 2013, 41:4743-4754.
112. Tebaldi T., et al. Widespread uncoupling between transcriptome and translatome variations after a stimulus in mammalian cells. BMC Genomics 2012, 13:220.
113. Auboeuf D., et al. A subset of nuclear receptor coregulators act as coupling proteins during synthesis and maturation of RNA transcripts. Mol. Cell. Biol. 2005, 25:5307-5316.
114. Bentley D.L. Coupling mRNA processing with transcription in time and space. Nat. Rev. Genet. 2014, 15:163-175.
115. Hsin J.P., Manley J.L. The RNA polymerase II CTD coordinates transcription and RNA processing. Genes Dev. 2012, 26:2119-2137.
116. Brown S.J., et al. Chromatin and epigenetic regulation of pre-mRNA processing. Hum. Mol. Genet. 2012, 21:R90-R96.
117. Dujardin G., et al. Transcriptional elongation and alternative splicing. Biochim. Biophys. Acta 2013, 1829:134-140.
118. Hazelbaker D.Z., et al. Kinetic competition between RNA polymerase II and Sen1-dependent transcription termination. Mol. Cell 2013, 49:55-66.
119. Pinto P.A., et al. RNA polymerase II kinetics in polo polyadenylation signal selection. EMBO J. 2011, 30:2431-2444.
120. Benson M.J., et al. Heterogeneous nuclear ribonucleoprotein L-like (hnRNPLL) and elongation factor, RNA polymerase II, 2 (ELL2) are regulators of mRNA processing in plasma cells. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:16252-16257.
121. Huang D.W., et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
122. Huang Y., et al. Mediator complex regulates alternative mRNA processing via the MED23 subunit. Mol. Cell 2012, 45:459-469.
123. Nagaike T., et al. Transcriptional activators enhance polyadenylation of mRNA precursors. Mol. Cell 2011, 41:409-418.
124. Martinson H.G. An active role for splicing in 3'-end formation. Wiley Interdiscip. Rev. RNA 2011, 2:459-470.
125. Berget S.M. Exon recognition in vertebrate splicing. J. Biol. Chem. 1995, 270:2411-2414.
126. Shi Y., et al. Molecular architecture of the human pre-mRNA 3' processing complex. Mol. Cell 2009, 33:365-376.
127. Lee K.M., Tarn W.Y. TRAP150 activates splicing in composite terminal exons. Nucleic Acids Res. 2014, Published online October 17, 2014. http://dx.doi.org/10.1093/nar/gku963.
128. Katz Y., et al. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat. Methods 2010, 7:1009-1015.
129. Kaida D., et al. U1 snRNP protects pre-mRNAs from premature cleavage and polyadenylation. Nature 2010, 468:664-668.
130. Tian B., et al. Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing. Genome Res. 2007, 17:156-165.
131. Luo W., et al. The conserved intronic cleavage and polyadenylation site of CstF-77 gene imparts control of 3' end processing activity through feedback autoregulation and by U1 snRNP. PLoS Genet. 2013, 9:e1003613.
132. Bava F.A., et al. CPEB1 coordinates alternative 3'-UTR formation with translational regulation. Nature 2013, 495:121-125.
133. Au K.F., et al. Characterization of the human ESC transcriptome by hybrid sequencing. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:E4821-E4830.
134. Sharon D., et al. A single-molecule long-read survey of the human transcriptome. Nat. Biotechnol. 2013, 31:1009-1014.
135. Sugnet C.W., et al. Transcriptome and genome conservation of alternative splicing events in humans and mice. Pac. Symp. Biocomput. 2004, 2004:66-77.
136. Sorek R., et al. How prevalent is functional alternative splicing in the human genome?. Trends Genet. 2004, 20:68-71.
137. Resch A., et al. Evidence for a subpopulation of conserved alternative splicing events under selection pressure for protein reading frame preservation. Nucleic Acids Res. 2004, 32:1261-1269.
138. Sorek R., et al. Minimal conditions for exonization of intronic sequences: 5' splice site formation in Alu exons. Mol. Cell 2014, 14:221-231.
139. Mortazavi A., et al. Mapping and quantifying mammalian transcriptomes by RNA-seq. Nat. Methods 2008, 5:621-628.
140. Zhang H., et al. Biased alternative polyadenylation in human tissues. Genome Biol. 2005, 6:R100.
141. Ji Z., et al. Progressive lengthening of 3' untranslated regions of mRNAs by alternative polyadenylation during mouse embryonic development. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:7028-7033.
142. Sandberg R., et al. Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites. Science 2008, 320:1643-1647.
143. Ji Z., Tian B. Reprogramming of 3'UTR untranslated regions of mRNAs by alternative polyadenylation in generation of pluripotent stem cells from different cell types. PLoS ONE 2009, 4:e8419.
144. Wethmar K. The regulatory potential of upstream open reading frames in eukaryotic gene expression. Wiley Interdiscip. Rev. RNA 2014, 5:765-778.
145. Vanderperre B., et al. Direct detection of alternative open reading frames translation products in human significantly expands the proteome. PLoS ONE 2013, 8:e70698.
146. Recoding: Expansion of Decoding Rules Enriches Gene Expression 2010, Springer. J.F. Atkins, F. Raymond (Eds.).
147. Atkins J.F., Baranov P.V. The distinction between recoding and codon reassignment. Genetics 2010, 185:1535-1536.